Relationships between rhinitis and asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 9, 1998, Pages 833-839

  Vignola, A M ^a   Chanez, P ^b   Godard, P ^b   Bousquet, J ^b,c  

^a CNR   (Italy)

^b INSERM   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CROMOGLYCATE DISODIUM; LORATADINE; MONTELUKAST; NEDOCROMIL; THEOPHYLLINE;

ALLERGENICITY; ALLERGIC RHINITIS; ASTHMA; DISEASE ASSOCIATION; DRUG CHOICE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0031684986     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03988.x     Document Type: Review

References (83)

1. Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991;46:895-901.
2. Neukirch F, Pin I, Knani J, et al. Prevalence of asthma and asthma-like symptoms in three French cities. Respir Med 1995;89:685-92.
3. Mygind N, Dirksen A, Johnsen NJ, Weeke B. Perennial rhinitis: an analysis of skin testing, serum IgE, and blood and smear eosinophilia in 201 patients. Clin Otolaryngol 1978;3:189-96.
4. Rossi OV, Pirila T, Laitinen J, Huhti E. Sinus aspirates and radiographic abnormalities in severe attacks of asthma. Int Arch Allergy Immunol 1994;103:209-13.
5. Szczeklik A. Aspirin-induced asthma: an update and novel findings. Adv Prostaglandin Thromboxane Leukot Res 1994;22:185-98.
6. Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990;323:502-7.
7. Peat JK, Tovey E, Toelle BG, et al. House dust mite allergens. A major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996;153:141-6.
8. Peat J, Tovey E, Mellis C, Leeder S, Woolcock A. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1973;23: 812-20.
9. Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J Allergy Clin Immunol 1992;90:579-88.
10. Kang BC, Wu CW, Johnson J. Characteristics and diagnoses of cockroach-sensitive bronchial asthma. Ann Allergy 1992;68:237-44; erratum 1992;69:174.
11. Charpin D, Hughes B, Mallea M, Sutra JP, Balansard G, Vervloet D. Seasonal allergic symptoms and their relation to pollen exposure in south-cast France. Clin Exp Allergy 1993;23:435-9.
12. Peat JK, Woolcock AJ. Sensitivity to common allergens: relation to respiratory symptoms and bronchial hyperresponsiveness in children from three different climatic areas of Australia. Clin Exp Allergy 1991;21:573-81.
13. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995;333:107-12.
14. Piirila P, Estlander T, Hytonen M, Keskinen H, Tupasela O, Tuppurainen M. Rhinitis caused by ninhydrin develops into occupational asthma. Eur Respir J 1997;10:1918-21.
15. Moscato G, Galdi E, Scibilia J, et al. Occupational asthma, rhinitis and urticaria due to piperacillin sodium in a pharmaceutical worker. Eur Respir J 1995;8:467-9.
16. Blumenthal M, Marcus-Bagley D, Awdeh Z, Johnson B, Yunis EJ, Alper CA. HLA-DR2 [HLA-B7, SC31, DR2] and [HLA-B8, SC01, DR3] haplotypes distinguish subjects with asthma from those with rhinitis only in ragweed pollen allergy. J Immunol 1992;148:411-16.
17. Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics 1994;94: 895-901.
18. Linna O, Kokkonen J, Lukin M. A 10-year prognosis for childhood allergic rhinitis. Acta Paediatr 1992;81:100-2.
19. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15:21-5.
20. Igarashi Y, Goldrich MS, Kaliner MA, Irani AM, Schwartz LB, White MV. Quantitation of inflammatory cells in the nasal mucosa of patients with allergic rhinitis and normal subjects. J Allergy Clin Immunol 1995;95: 716-25.
21. Holmberg K, Bake B, Pipkorn U. Nasal mucosal blood flow after intranasal allergen challenge. J Allergy Clin Immunol 1988;81:541-7.
22. Anggard A. Basic mechanisms in autonomic nervous responses in specific and nonspecific nasal hyperreactivity. Acta Otolaryngol (Stockh) 1993;113:394-6.
23. Baraniuk JN, Kaliner MA. Neuropeptides and nasal secretion. J Allergy Clin Immunol 1990;86:620-7.
24. Bousquet J, Vignola M, Campbell A, Michel F. Mechanisms of allergic rhinitis. Int Arch Allergy Immunol 1996;110:207-18.
25. Baraniuk JN. Neural receptors and asthma. Allergy Proc 1995;16:227-33.
26. Laitinen LA, Laitinen A. Innervation of airway smooth muscle. Am Rev Respir Dis 1987;136:S38-42.
27. Howarth PH, Springall DR, Redington AE, Djukanovic R, Holgate ST, Polak JM. Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. Am J Respir Cell Mol Biol 1995;13:288-96.
28. Joos GF, Germonpre PR, Kips JC, Peleman RA, Pauwels RA. Sensory neuropeptides and the human lower airways: present state and future directions. Eur Respir J 1994;7: 1161-71.
29. Barnes PJ. Is asthma a nervous disease? The Parker B. Francis Lectureship. Chest 1995;107:119-25S.
30. Lane AP, Prazma J, Baggett HC, Rose AS, Pillsbury HC. Nitric oxide is a mediator of neurogenic vascular exudation in the nose. Otolaryngol Head Neck Surg 1997;116: 294-300.
31. Barnes PJ. NO or no NO in asthma? Thorax 1996;51: 218-20.
32. Lundberg JO, Weitzberg E, Lundberg JM, Alving K. Nitric oxide in exhaled air. Eur Respir J 1996;9:2671-80.
33. Bentley AM, Jacobson MR, Cumberworth V, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992;89:877-83.
34. Bousquet J, Chanez P, Campbell AM, Vignola AM, Godard P. Cellular inflammation in asthma. Clin Exp Allergy 1995;2:39-42.
35. Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 1995;151:1900-6.
36. al-Ghamdi K, Ghaffar O, Small P, Frenkiel S, Hamid Q. IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol 1997;26:160-6.
37. Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997;99:S763-72.
38. Sousa AR, Poston RN, Lane SJ, Nakhosteen JA, Lee TH. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 1993;147:1557-61.
39. Ying S, Robinson DS, Meng Q, et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997; 27:3507-16.
40. Minshall EM, Cameron L, Lavigne F, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997;17:683-90.
41. Altman GB, Altman LC, Luchtel DL, Jabbour AJ, Baker C. Release of RANTES from nasal and bronchial epithelial cells. Cell Biol Toxicol 1997;13:205-13.
42. Vignola AM, Campbell AM, Chanez P, et al. HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. Am Rev Respir Dis 1993; 148:689-94.
43. Montefort S, Holgate ST, Howarth PH. Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur Respir J 1993;6:1044-54.
44. Canonica GW, Ciprandi G, Pesce GP, Buscaglia S, Paolieri F, Bagnasco M. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995;107:99-102.
45. Gosset P, Tillie-Leblond I, Janin A, et al. Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int Arch Allergy Immunol 1995;106:69-77.
46. Djukanovic R, Lai CK, Wilson JW, et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992;5: 538-44.
47. Chakir J, Laviolette M, Boutet M, Laliberte R, Dube J, Boulet LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest 1996;75:735-44.
48. Calhoun WJ, Jarjour NN, Gleich GJ, Stevens CA, Busse WW. Increased airway inflammation with segmental versus aerosol antigen challenge. Am Rev Respir Dis 1993;147: 1465-71.
49. Foresi A, Leone C, Pelucchi A, et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J Allergy Clin Immunol 1997;100:58-64.
50. Jeffery P. Bronchial biopsies and airway inflammation. Eur Respir J 1996;9:1583-7.
51. Lim MC, Taylor RM, Naclerio RM. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med 1995;151:136-44.
52. Ingels K, Durdurez J-P, Cuvelier C, van Cauwenberge P. Nasal biopsy is superior to nasal smear for finding eosinophils in nonallergic rhinitis. Allergy 1997;52:338-41.
53. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol 1992;89:611-18.
54. Townley R, Ryo U, Kolotin B, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975;56:429-37.
55. Sotomayor H, Badier M, Vervloet D, Orehek J. Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen. Reversal by corticosteroids. Am Rev Respir Dis 1984;130:56-8.
56. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol 1985;75:573-7.
57. Aubier M, Levy J, Clerici C, Neukirch F, Cabrieres F, Herman D. Protective effect of theophylline on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1991;143:346-50.
58. Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146: 122-6.
59. 1 and bronchial hyperresponsiveness in an epidemiological study. Eur Respir J 1992;5:1104-10.
60. Leynaert B, Bousquet J, Henry C, Liard R, Neukirch F. Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study. Am J Respir Crit Care Med 1997;156:1413-20.
61. Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997;99:S781-6.
62. Bucca C, Rolla G, Brussino L, De-Rose V, Bugiani M. Are asthma-like symptoms due to bronchial or extrathoracic airway dysfunction? Lancet 1995;346:791-5.
63. Busse WW. The role of respiratory infections in airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1994;150:S77-9.
64. Johnston SL, Bardin PG, Pattemore PK. Viruses as precipitants of asthma symptoms. III. Rhinoviruses: molecular biology and prospects for future intervention. Clin Exp Allergy 1993;23:237-46.
65. Lemanske R Jr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989;83:1-10.
66. Sterk PJ. Virus-induced airway hyperresponsiveness in man. Eur Respir J 1993;6:894-902.
67. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994;94:2200-8.
68. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995;151:879-86.
69. International Consensus Report on the Diagnosis and Management of Rhinitis. Allergy 1994;49 Suppl 19:1-33.
70. Global strategy for asthma management and prevention. WHO/NHLBI workshop report. National Institutes of Health, National Heart, Lung and Blood Institute, Publication no. 95-3659 1995.
71. Norman PS. Is there a role for immunotherapy in the treatment of asthma? Yes. Am J Respir Crit Care Med 1996;154:1225-6.
72. Barnes PJ. Is there a role for immunotherapy in the treatment of asthma? No. Am J Respir Crit Care Med 1996;154:1227-8.
73. Bousquet J, Lockey R, Malling H-J. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53 Suppl 44.
74. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993;91:97-101.
75. Pedersen B, Dahl R, Lindqvist N, Mygind N. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma. Allergy 1990;45:451-6.
76. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274-82.
77. Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984; 130:1014-18.
78. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90:250-6.
79. Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-32.
80. Bousquet J, Godard P, Michel FB. Antihistamines in the treatment of asthma. Eur Respir J 1992;5:1137-42.
81. van-Ganse E, Kaufman L, Derde MR Yernault JC, Delaunois L, Vincken W. Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J 1997;10:2216-24.
82. Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997;100:781-8.
83. Naclerio RM, Bartenfelder D, Proud D, et al. Theophylline reduces the response to nasal challenge with antigen. Am J Med 1985;79:43-7.